The ABP is now set to launch another module to detect use of growth hormone (GH)—that has remained a challenging factor for testers. At the ongoing three-day WADA symposium on ABP in New Delhi, the new module was part of the discussion besides looking at recent trends and challenges ahead.

“Over 190 anti-doping organisations now run the ABP programme and they have a variety of experiences to share. There was a great exchange of knowledge with various national anti-doping organisations and stakeholders,” says Dr Reid Aikin, WADA’s Associate Director responsible for the ABP Programme.

Since the introduction of ABP, there has been a major change in the behaviour of athletes who now use their off season or start of training as doping periods, says Aikin. “Classically, people would dope in the period before competition so they can derive the most benefit. But now anti-doping organisations know that and test during that period. So one of the things we have seen over the past years is that cheaters have shifted their periods of doping very far from competition and during the training phase with the idea that the effect of drugs carries through to the competition,” he says.

However, it may not have the same impact on their performances as one can have while using performance enhancing drugs closer to competition. “It reduces the effectiveness of their doping during competitions, so we can look at it as a victory for anti-doping programme.”

The passport can also be used as a tool to identify suspicious athletes, investigate and further test them. “With the first module launched for blood doping (in 2010), we have had over 200 sanctions where the only evidence was the biological passport data.”

“Also, EPO detection went up almost three-fold upon the introduction of the ABP. Over the years, that amounts to hundreds of athletes who have been targeted as positive for EPO using the passport.”

With the launch of an endocrine module (the second module) to detect growth hormone abuse, it will be a big boost to the anti-doping measures. “These three—blood doping, steroids and GH doping—are important substance classes. These were many famous doping cases that had all three at the same time. Over time we will continue to add in more layers and modules to ABP to expand the number of substances that are detectable,” Aikin says.

‘NADA serious on dope fight’

The National Dope Testing Laboratory here is also in the process of setting up an Athlete Passport Management Unit (APMU). The symposium would help India strengthen its anti-doping programme. “We have been able to exchange information on best practices that will benefit everyone. They (NADA) are taking it seriously, and looking for growth. Anti-doping programme requires funding and depends on tests and how many tests are properly distributed at the right time.”